Déjà vu for primary aldosteronism

The Lancet

Volumn 371, Issue 9628, 2008, Pages 1890-1891

  Kaplan, Norman M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; RENIN; SPIRONOLACTONE;

ADRENAL DISEASE; ADRENAL HYPERPLASIA; ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION RESPONSE; DEJA VU; HYPERTENSION; HYPOKALEMIA; MONOTHERAPY; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

EID: 44649117470     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60809-0     Document Type: Note

References (12)

1. Douma S., Konstantinos P., Doumas M., et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371 (2008) 1915-1920
2. Conn J., Cohen E., Rovner D., and Nesbit R. Normokalemic primary aldosteronism: a detectable cause of curable "essential hypertension". JAMA 193 (1965) 200-206
3. Gordon R., Klemm S., Stowasser M., Tunny T., Storie W., and Rutherford J. How common is primary aldosteronism? Is it the most frequent cause of curable hypertension?. J Hypertens 11 suppl (1993) S310-S311
4. Rayner B., Opie L., and Davidson J. The aldosterone/renin ratio as a screening test for primary aldosteronism. S Afr Med J 90 (2000) 394-400
5. Douma S., Petidis K., Vogiatzis K., and Zamboulis C. The aldosterone/PRA ratio (ARR) application in the diagnosis of primary aldosteronism. J Hypertens 19 suppl 2 (2001) S12 (abstr).
6. Calhoun D., Nishizaka M., Zaman M., Thakkar R., and Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40 (2002) 892-896
7. Strauch B., Zelinka T., Hampf M., Bernhardt R., and Widimsky Jr. J. Prevalence of primary hyperaldosteronism among hypertensive patients. J Human Hypertens 17 (2003) 349-352
8. Giachetti G., Ronconi V., Lucarelli G., Boscaro M., and Mantero F. Analysis of screening and confirmatory test in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens 24 (2006) 737-745
9. Nwariaku F., Miller B., Auchus R., et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 141 (2006) 497-502
10. Rossi G., Pessina A., and Heagerty A. Primary aldosteronism: an update on screening, diagnosis, and treatment. J Hypertens 26 (2008) 613-621
11. Kaplan N. Is there an unrecognized epidemic of primary aldosteronism?. Hypertension 3 (2007) 454-458
12. Swales J. Primary aldosteronism: how hard should we look?. BMJ (Clin Res Ed) 287 (1983) 702-703